# Cambrex Charles City, Inc. – FDA Inspection, Mar 26, 2010

Source: https://www.keypedia.com/records/fda_inspections/cambrex-charles-city-inc/f6bb2328-f4e5-4151-abc7-95470a5f670c
Source feed: FDA_Inspections

> FDA inspection 653275 of Cambrex Charles City, Inc., March 26, 2010. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 653275
- Company Name: Cambrex Charles City, Inc.
- Inspection Date: 2010-03-26
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1266564 - 2025-03-07](https://www.keypedia.com/records/fda_inspections/cambrex-charles-city-inc/bd4a48d6-1e7e-49c5-bf07-f30760432852)
- FDA Inspection 1169072 - 2022-05-02
- [FDA Inspection 1009802 - 2016-12-22](https://www.keypedia.com/records/fda_inspections/cambrex-charles-city-inc/de2f03c8-7b22-46af-bf45-3f3f219687b5)
- FDA Inspection 868083 - 2014-02-27
- [FDA Inspection 843001 - 2013-08-02](https://www.keypedia.com/records/fda_inspections/cambrex-charles-city-inc/147242f0-cce7-4513-bca0-cfa211d9eb76)

Company: https://www.keypedia.com/companies/cambrex-charles-city-inc/b14d342b-e5ae-4df6-ad7a-39cd62dfb9c6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c